SCHEMBL19882160

SCHEMBL19882160

C=C(CNCc1ccc(N)cc1)NCC1CCCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 2/20 0.45
▸ EPHX1 P07099 2/20 0.45
▸ HDAC3 O15379 2/20 0.41
▸ HDAC4 P56524 1/20 0.41
▸ HDAC1 Q13547 1/20 0.41
▸ HDAC8 Q9BY41 1/20 0.41
▸ HDAC5 Q9UQL6 1/20 0.41
▸ RAB9A P51151 4/20 0.39
▸ NPC1 O15118 3/20 0.39
▸ POLB P06746 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ PPID Q08752 2/20 0.37
▸ OPRM1 P35372 1/20 0.37
▸ OPRD1 P41143 1/20 0.37
▸ OPRK1 P41145 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ METTL3 Q86U44 1/20 0.36
▸ ITGB3 P05106 1/20 0.36
▸ ITGB1 P05556 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15832176 0.86 EPHX1 (0.46) HDAC6EPHX1HDAC3RAB9ANPC1
SCHEMBL3085761 0.83 HDAC6 (0.60) HDAC6EPHX1HDAC3HDAC4HDAC1
Hydrochloric Acid SCHEMBL3857669 0.82 HDAC6 (0.59) HDAC6EPHX1HDAC3HDAC4HDAC1
SCHEMBL13573606 0.78 HDAC6 (0.49) HDAC6EPHX1HDAC3HDAC4HDAC1
SCHEMBL7248082 0.70 HDAC6 (0.60) HDAC6HDAC3HDAC4HDAC1HDAC8
SCHEMBL11782827 0.70 ALDH1A1 (0.45) HDAC6EPHX1HDAC3HDAC4HDAC1
SCHEMBL19882179 0.70 CA12 (0.49) PPIDALDH1A1TSHRITGB3ITGB1
SCHEMBL3861590 0.68 HDAC6 (0.62) HDAC6HDAC3HDAC4HDAC1HDAC8
SCHEMBL24331631 0.68 CA2 (0.67) HDAC6HDAC3HDAC1POLBSMN1; SMN2
SCHEMBL15832149 0.68 EPHX1 (0.41) EPHX1RAB9ANPC1POLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2516387-B1 INHIBITORS OF CYCLOPHILINS FOR USE IN THE PREVENTION AND/OR THE TREATMENT OF VIRAL PATHOLOGIES OR INFECTIONS INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECH MÉDICALE (INSERM) (FR) 2018-02-21 — — EP disclosed
Send feedback